Notice of Available Space for Vendors at the 2009 NIH Glycoscience Research Day, 23423-23424 [E9-11574]

Download as PDF Federal Register / Vol. 74, No. 95 / Tuesday, May 19, 2009 / Notices announces the following aforementioned committee meeting: Time and Date: 9:30 a.m.–11 a.m., June 4, 2009. Place: The teleconference call will originate at the Centers for Disease Control and Prevention in Atlanta, Georgia. Please see SUPPLEMENTARY INFORMATION for details on accessing the teleconference. Status: Open to the public, teleconference access limited only by availability of telephone ports. Purpose: The committee will provide advice to the Director, CDC on broad strategies and policy issues facing CDC. Matters To Be Discussed: The committee will discuss and vote on recommendations regarding CDC Budget Challenges for Fiscal Year 2009 and beyond; discuss and vote on the updated recommendations from the National Biosurveillance Advisory Subcommittee; discuss and vote on the mission of the Health Disparities Subcommittee; discuss and vote on the Ethic Subcommittee’s documents entitled, ‘‘Recommendation on Ethical Aspects of Compulsory Use of Travel Restriction Tools’’; and ‘‘Requesting Department of Homeland Security Assistance for Control of Communicable Diseases: Standard Operating Procedures;’’ and discussion of the committee’s charge, ‘‘Ethics Subcommittee Input on the Role of Social Determinants in Health Reform.’’ Agenda items are subject to change as priorities dictate. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group, (NCIPC IRG) Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel K, Funding Opportunity Announcement (FOA) PAR07–231, Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following teleconference meeting: Perkins, M.D., M.B.A., Designated Federal Official, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S D–14, Atlanta, Georgia 30333. Telephone 404–639–7000. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Time and Date: 12:30 p.m.–12:45 p.m., June 2, 2009 (Open). 12:45 p.m.–7 p.m., June 2, 2009 (Closed). Place: Teleconference, Toll Free: 877–468– 4185, Participant Pass Code: 3772769. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications submitted in response to Fiscal Year 2009 Requests for Applications related to the following individual research announcement: RFA– EH–09–001 Climate Change: Environmental Impact on Human Health (U01). Agenda items are subject to change as priorities dictate. Contact Person for More Information: Rick Waxweiler, PhD, Director, Extramural Research Program Office, National Center for Injury Prevention & Control and Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S F–62, Atlanta, Georgia 30341, Telephone 770–488–4850. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 13, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–11599 Filed 5–18–09; 8:45 am] Dated: May 13, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–11600 Filed 5–18–09; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P To participate in the teleconference, please dial 1–888–820–8958 and enter pass code 6034485. SUPPLEMENTARY INFORMATION: mstockstill on PROD1PC66 with NOTICES FOR FURTHER INFORMATION CONTACT: VerDate Nov<24>2008 16:48 May 18, 2009 Brad Jkt 217001 23423 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 10 a.m.–12 p.m., June 4, 2009 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘CDC Grants for Public Health Research Dissertation, Panel K, FOA PAR07– 231.’’ Contact Person for More Information: Susan B. Stanton, D.D.S., Scientific Review Officer, Office of the Director, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–4640. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 13, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–11601 Filed 5–18–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Available Space for Vendors at the 2009 NIH Glycoscience Research Day The purpose of this notice is to inform the public of the availability of limited vendor space at the 2009 NIH Glycoscience Research Day. This meeting is organized by the NIH Glycobiology Special Interest Group. E:\FR\FM\19MYN1.SGM 19MYN1 23424 Federal Register / Vol. 74, No. 95 / Tuesday, May 19, 2009 / Notices The meeting will be held on May 28, 2009, at the National Institutes of Health, Building 45 (Natcher Conference Center), on the Auditorium Balcony B and C and the Natcher Fourier, from 8:25 a.m. to 5 p.m. The doors will open at 7 a.m. The purpose of this meeting is for presentation and discussion of scientific work performed by scientists at the National Institutes of Health and surrounding universities in the area of the glycosciences. The meeting agenda is available Online at https:// meetings.nigms.nih.gov/index.cfm? event=home&ID=6185. The meeting will be open to the public, including vendors, with attendance limited to the space available. Individuals who plan to attend and need special assistance, such as sign language or other reasonable accommodations, should notify Mary Conway, Conference Coordinator, Natcher Conference Center, at 301–594– 7007. In the interest of security, NIH has instituted security procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, and hotel and airport shuttles will be inspected prior to entry onto campus. Visitors will be required to present one form of identification and to state the purpose of their visit. Acceptable forms of identification include a governmentissued photo ID, driver’s license or passport. For additional information concerning this meeting, please contact Dr. John F. Cipollo, Chair of the 2009 NIH Glycoscience Research Day, Principal Investigator, Food and Drug Administration Center for Biologics Evaluation and Research Division of Bacterial, Parasitic and Allergenic Products, Building 29, Room 126, 8800 Rockville Pike, Bethesda MD 20892– 0001, telephone 301–827–0162 (office). Dated: May 11, 2009. Raynard S. Kington, Acting Director, National Institutes of Health. [FR Doc. E9–11574 Filed 5–18–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on PROD1PC66 with NOTICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the VerDate Nov<24>2008 16:48 May 18, 2009 Jkt 217001 National Advisory Child Health and Human Development Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Child Health and Human Development Council. Date: June 11, 2009. Open: 8 a.m. to 12:30 p.m. Agenda: (1) A report by the Director, NICHD; (2) Report of the Subcommittee on Planning and Policy; (3) Endocrinology, Nutrition and Growth Branch Presentation; (4) An update on American Recovery and Reinvestment Act activities; and other business of the Council. Place: National Institutes of Health, Building 31, 31 Center Drive, C-Wing, Conference Room 6, Bethesda, MD 20892. Closed: 1:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Contact Person: Yvonne T. Maddox, PhD, Deputy Director, National Institute of Child Health and Human Development, NIH, 9000 Rockville Pike MSC 7510, Building 31, Room 2A03, Bethesda, MD 20892, (301) 496–1848. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/nachhd.htm, where an agenda and any additional information for the meeting will be posted when available. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 In order to facilitate public attendance at the open session of Council, reserved seating will be made available to the first five individuals reserving seats in the main meeting room, Conference Room 6. Please contact Ms. Lisa Kaeser, NICHD Program and Public Liaison Office, NICHD, at 301–496– 0536 to make your reservation. Additional seating will be available in the meeting overflow rooms, Conference Rooms 7 and 8. Individuals will also be able to view the meeting via NIH Videocast. Please go to the following link for Videocast access instructions at https://www.nichd.nih.gov/ about/overview/advisory/nachhd/virtualmeeting-200905.cfm. Meeting material will be available on the NICHD Web site at https:// www.nichd.nih.gov/about/overview/ advisory/nachhd/. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: May 12, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–11576 Filed 5–18–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Biodemographic Factors of Longevity II. Date: June 24, 2009. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20814, (Telephone Conference Call). Contact Person: Bita Nakhai, PhD, Scientific Review Officer, Scientific Review E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 74, Number 95 (Tuesday, May 19, 2009)]
[Notices]
[Pages 23423-23424]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11574]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Available Space for Vendors at the 2009 NIH 
Glycoscience Research Day

    The purpose of this notice is to inform the public of the 
availability of limited vendor space at the 2009 NIH Glycoscience 
Research Day. This meeting is organized by the NIH Glycobiology Special 
Interest Group.

[[Page 23424]]

    The meeting will be held on May 28, 2009, at the National 
Institutes of Health, Building 45 (Natcher Conference Center), on the 
Auditorium Balcony B and C and the Natcher Fourier, from 8:25 a.m. to 5 
p.m. The doors will open at 7 a.m.
    The purpose of this meeting is for presentation and discussion of 
scientific work performed by scientists at the National Institutes of 
Health and surrounding universities in the area of the glycosciences. 
The meeting agenda is available Online at https://meetings.nigms.nih.gov/index.cfm?event=home&ID=6185.
    The meeting will be open to the public, including vendors, with 
attendance limited to the space available. Individuals who plan to 
attend and need special assistance, such as sign language or other 
reasonable accommodations, should notify Mary Conway, Conference 
Coordinator, Natcher Conference Center, at 301-594-7007.
    In the interest of security, NIH has instituted security procedures 
for entrance onto the NIH campus. All visitor vehicles, including 
taxicabs, and hotel and airport shuttles will be inspected prior to 
entry onto campus. Visitors will be required to present one form of 
identification and to state the purpose of their visit. Acceptable 
forms of identification include a government-issued photo ID, driver's 
license or passport.
    For additional information concerning this meeting, please contact 
Dr. John F. Cipollo, Chair of the 2009 NIH Glycoscience Research Day, 
Principal Investigator, Food and Drug Administration Center for 
Biologics Evaluation and Research Division of Bacterial, Parasitic and 
Allergenic Products, Building 29, Room 126, 8800 Rockville Pike, 
Bethesda MD 20892-0001, telephone 301-827-0162 (office).

    Dated: May 11, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9-11574 Filed 5-18-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.